3-FACTOR VERSUS 4-FACTOR PCC IN COAGULOPATHY OF TRAUMA: FOUR IS BETTER THAN THREE

被引:20
作者
Zeeshan, Muhammad [1 ]
Hamidi, Mohammad [1 ]
Kulvatunyou, Narong [1 ]
Jehan, Faisal [1 ]
O'Keeffe, Terence [1 ]
Khan, Muhammad [1 ]
Rashdan, Lana [1 ]
Tang, Andrew [1 ]
Zakaria, El-Rasheid [1 ]
Joseph, Bellal [1 ]
机构
[1] Univ Arizona, Dept Surg, Div Trauma Crit Care Emergency Surg & Burns, Tucson, AZ USA
来源
SHOCK | 2019年 / 52卷 / 01期
关键词
4-factor PCC versus 3-factor PCC; coagulopathy of trauma; COT; factor replacement; prothrombin complex concentrate; PROTHROMBIN COMPLEX CONCENTRATE; INJURED PATIENTS; RESUSCITATION; MORTALITY; REVERSAL; EFFICACY; OUTCOMES; PLASMA;
D O I
10.1097/SHK.0000000000001240
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Introduction: Coagulopathy of trauma (COT) is common and highly lethal. Prothrombin complex concentrate (PCC) has been advocated for correction of COT. However, the difference in efficacy between three-factor PCC (3PCC) versus four-factor PCC (4-PCC) remains unclear. The aim of our study was to compare efficacy of 3-PCC versus 4PCC in COT. Methods: Five-year (2013-2017) review of coagulopathic trauma patients at our Level-I trauma center who received 3-or 4-PCC. Patients were divided into two groups (4-PCC and 3-PCC) and matched in 1: 1 ratio using propensity-score-matching for demographics, injury parameters, admission vitals, and hematological parameters. Primary outcomes were time to correction of international normalized ratio (INR), blood products transfusion, thromboembolic complications, and mortality. Secondary outcomes were hospital-length of stay (LOS), intensive care unit (ICU)LOS, cost of therapy, and total hospital cost. Results: Six hundred fifty-seven patients met inclusion criteria of whom 250 patients (4-PCC: 125; 3-PCC: 125) were matched. The mean age was 50 +/- 19.4 y, 64% were male, and median-injury severity score was 24[15-33]. 4-PCC was associated with accelerated correction of INR (365 vs. 428 min, P = 0.01), decrease in red blood cells (7 units vs. 10 units, P = 0.04) and FFP (6 units vs. 8 units, P = 0.03) transfused. There was no difference in platelet transfusion, thromboembolic complications, mortality, hospital, and ICU-LOS. 4-PCC was associated with higher cost of PCC therapy, and lower cost of transfusion. There was no difference regarding the total hospital cost between the two groups. Conclusion: Compared with 3-factor PCC, the use of 4-factor PCC is associated with a rapid reversal of INR and reduction in transfusion requirement without increasing the overall hospital cost or the risk of thromboembolic events. 4-PCC may be preferred as an adjunct for the resuscitation of coagulopathic trauma patients.
引用
收藏
页码:23 / 28
页数:6
相关论文
共 32 条
  • [1] Lethal injuries and time to death in a level I trauma center
    Acosta, JA
    Yang, JC
    Winchell, RJ
    Simons, RK
    Fortlage, DA
    Hollingsworth-Fridlund, P
    Hoyt, DB
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 1998, 186 (05) : 528 - 533
  • [2] Administration FaD, KCENTR APPR
  • [3] Acute traumatic coagulopathy
    Brohi, K
    Singh, J
    Heron, M
    Coats, T
    [J]. JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE, 2003, 54 (06): : 1127 - 1130
  • [4] Prothrombin Complex Concentrate Versus Standard Therapies for INR Reversal in Trauma Patients Receiving Warfarin
    Chapman, Scott A.
    Irwin, Eric D.
    Beal, Alan L.
    Kulinski, Nichole M.
    Hutson, Katherine E.
    Thorson, Melissa A. L.
    [J]. ANNALS OF PHARMACOTHERAPY, 2011, 45 (7-8) : 869 - 875
  • [5] The cellular, metabolic, and systemic consequences of aggressive fluid resuscitation strategies
    Cotton, Bryan A.
    Guy, Jeffrey S.
    Morris, John A., Jr.
    Abumrad, Naji N.
    [J]. SHOCK, 2006, 26 (02): : 115 - 121
  • [6] Room for (Performance) Improvement: Provider-Related Factors Associated With Poor Outcomes in Massive Transfusion
    Cotton, Bryan A.
    Dossett, Lesly A.
    Au, Brigham K.
    Nunez, Timothy C.
    Robertson, Amy M.
    Young, Pampee P.
    [J]. JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE, 2009, 67 (05): : 1004 - 1012
  • [7] Prothrombin complex concentrate versus recombinant factor VIIa for reversal of coumarin anticoagulation
    Dickneite, Gerhard
    [J]. THROMBOSIS RESEARCH, 2007, 119 (05) : 643 - 651
  • [8] Prothrombin Complex Concentrate Versus Recombinant Factor VIIa for Reversal of Hemodilutional Coagulopathy in a Porcine Trauma Model
    Dickneite, Gerhard
    Doerr, Baerbel
    Kaspereit, Franz
    Tanaka, Kenichi A.
    [J]. JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE, 2010, 68 (05): : 1151 - 1157
  • [9] Three-Factor Versus Four-Factor Prothrombin Complex Concentrate for the Emergent Management of Warfarin-Associated Intracranial Hemorrhage
    Fischer, Daniel
    Sorensen, Jeffrey
    Fontaine, Gabriel V.
    [J]. NEUROCRITICAL CARE, 2018, 28 (01) : 43 - 50
  • [10] Prothrombin Complex Concentrates in Trauma and Perioperative Bleeding
    Grottke, Oliver
    Levy, Jerrold H.
    [J]. ANESTHESIOLOGY, 2015, 122 (04) : 923 - 931